In six pages cachexia is defined and considered as this condition relates to acutely ill cancer patients. Ten sources are cited in the bibliography.
Name of Research Paper File: D0_BWcachex.rtf
Unformatted Sample Text from the Research Paper:
complex syndrome and accounts for nearly a third of cancer deaths. Cachexia is characterized by weight loss, anorexia, weakness, anemia, and asthenia. Bibliography lists 10 sources. BWcachex.rtf
Cancer Cachexia and the Nutritional Needs of Acutely Ill Cancer Patients By: C.B. Rodgers - November 2001 --
for more information on using this paper properly! Introduction People who must live with chronic diseases such as HIV-AIDS or cancer (especially those that result in tumors
of the pancreas, stomach, colon, and lung) often experience a life-threatening muscle wasting syndrome known as cachexia. Tisdale (2000) explains: "Cachexia is characterized by a dramatic loss of triglycerides from
adipose tissue and proteins from skeletal muscle. Although it superficially resembles starvation, it is refractory to nutritional intervention. Loss of skeletal muscle mass results in lowered mobility and, hence, a
poorer quality of life for the patient, while erosion of respiratory muscle eventually leads to death from pneumonia. Cachexia is associated with reduced survival time irrespective of tumor mass or
the presence of metastases, and it also interferes with cancer therapy" (pp. 2293). Obviously, cachexia is a horrific condition with virtually no positive outcomes. However, researchers and clinicians are constantly
seeking new means of therapeutic intervention for treatment of cachexia. Argiles and Lopezsoriano (1997) even go so far as to state their research-based belief that: "Cancer cachexia is a complex
syndrome accounting for nearly a third of cancer deaths, characterized by weight loss, anorexia, weakness, anaemia, and asthenia. The complications associated with the appearance of the cachectic syndrome affect both
the physiological and biochemical balance of the patient, and have effects on the efficiency of the anticancer treatment" (pp. 565). Ross and Alexander (2001) add: "Little is known about the